Focusing and sustaining the antitumor CTL effector killer response by agonist anti-CD137 mAb | PNAS
Soluble CD137 as a dynamic biomarker to monitor agonist CD137 immunotherapies | Journal for ImmunoTherapy of Cancer
CD137 is a Useful Marker for Identifying CD4+ T Cell Responses to Mycobacterium tuberculosis - Yan - 2017 - Scandinavian Journal of Immunology - Wiley Online Library
Cancers | Free Full-Text | CD137 as an Attractive T Cell Co-Stimulatory Target in the TNFRSF for Immuno-Oncology Drug Development
Contributions of Costimulatory Molecule CD137 in Endothelial Cells | Journal of the American Heart Association
CD137 (4-1BB) costimulation of CD8+ T cells is more potent when provided in cis than in trans with respect to CD3-TCR stimulation | Nature Communications
Immune regulation by trogocytic CD137 transfer. (A) the cross-linking... | Download Scientific Diagram
Optimization of conditions for positive selection. a Expression... | Download Scientific Diagram
CD137: An Important Target in T Cell Co-Stimulation
CD137 and CD137L Immune Checkpoints for Immuno-oncology Research from Adipogen Life Sciences
Simultaneous monitoring assay for T-cell receptor stimulation-dependent activation of CD4 and CD8 T cells using inducible markers on the cell surface - ScienceDirect
CD137 (4-1BB) costimulation of CD8+ T cells is more potent when provided in cis than in trans with respect to CD3-TCR stimulation | Nature Communications
Ex vivo enrichment of PRAME antigen‐specific T cells for adoptive immunotherapy using CD137 activation marker selection - Lee - 2020 - Clinical & Translational Immunology - Wiley Online Library
CD137 costimulation enhances the antiviral activity of Vγ9Vδ2-T cells against influenza virus | Signal Transduction and Targeted Therapy
Activation-induced expression of CD137 permits detection, isolation, and expansion of the full repertoire of CD8+ T cells responding to antigen without requiring knowledge of epitope specificities - ScienceDirect
Soluble CD137 as a dynamic biomarker to monitor agonist CD137 immunotherapies | Journal for ImmunoTherapy of Cancer
CD137 expression on human NK cells associates with phenotypic markers... | Download Scientific Diagram
CD137 promotes bone metastasis of breast cancer by enhancing the migration and osteoclast differentiation of monocytes/macrophages
The IRF4-CD137 assay detects Ag-specific CD8 1 T cells with low... | Download Scientific Diagram
CD137 Antibody, anti-human, REAfinity™ | Recombinant antibodies | MACS Antibodies | Products | Miltenyi Biotec | Great Britain
CD137 expression marks antigen-responsive CD8 + T cells in the... | Download Scientific Diagram
CD137 (4-1BB) costimulation of CD8+ T cells is more potent when provided in cis than in trans with respect to CD3-TCR stimulation | Nature Communications
Soluble CD137 as a dynamic biomarker to monitor agonist CD137 immunotherapies | Journal for ImmunoTherapy of Cancer
Frontiers | CD137+CD154− Expression As a Regulatory T Cell (Treg)-Specific Activation Signature for Identification and Sorting of Stable Human Tregs from In Vitro Expansion Cultures
Frontiers | CD137+CD154− Expression As a Regulatory T Cell (Treg)-Specific Activation Signature for Identification and Sorting of Stable Human Tregs from In Vitro Expansion Cultures
